Clinical Trial Detail

NCT ID NCT03211117
Title Pembrolizumab, Chemotherapy, and Radiation Therapy With or Without Surgery in Treating Patients With Anaplastic Thyroid Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Mayo Clinic
Indications

thyroid gland cancer

Therapies

Docetaxel + Doxorubicin + Pembrolizumab

Age Groups: senior adult

No variant requirements are available.